BSG and cardiovascular disorder: CyPA promotes inflammatory responses and platelet activation by interacting with receptors such as CD147 (EMMPRIN) and RAGE (receptor for advanced glycation end products), thereby playing an essential role in the onset and progression of cardiovascular diseases (3, 17, 18).